Derivatization of Apo-Low-Density Lipoprotein Lysine Residues by Lipid Peroxidation Products during Low-Density Lipoprotein Oxidation

  • Urs Peter Steinbrecher
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


Cultured endothelial cells or arterial smooth muscle cells have previously been shown to promote LDL oxidation. Oxidized LDL is not recognized by the LDL receptor of fibroblasts but is rapidly degraded by macrophages via the “scavenger” receptor pathway. The present studies were done to determine if these changes in receptor recognition might result from derivatization of lysine residues of apo B by products formed during the peroxidation of LDL lipids. Modification of lysine groups was suggested by a decrease of up to 50% in trinitrobenzenesulfonic acid reactivity in oxidized or endothelial cell modified LDL. Amino-acid analysis confirmed that this resulted mainly from loss of lysine. To determine if the change in lysine occurred through derivation by lipid peroxidation products, LDL was labeled with trace amounts of 2-[l-14C]-or 2-[5,6,8,9,11,12,14,15-3H]arachidonylphosphatidylcholine. After oxidation by exposure to 5 μM CuSO4 for 24 hr, the radioactivity bound to protein was significantly greater than that in nonoxidized control LDL or in oxidized LDL labeled with 2-[l-14C]palmitoylphosphatidylcholine. Ultrafiltration revealed that 20-30% of the total label from arachi-donate was released from LDL during oxidation; nearly all of this radioactivity was in material more polar than peroxidized fatty acids. The protein component of oxidized LDL was highly fluorescent, with excitation and emission maxima of 350 and 433 nm, respectively. These results support the hypothesis that LDL oxidation leads to scission of polyunsaturated fatty acids with release of aldehyde products that then form fluorescent adducts with lysine ε-amino groups. This modification of lysines may explain the altered biological properties of oxidized or endothelial-cell-modified LDL.


Lipid Peroxidation Product Familial Hypercholesterolemia Arterial Smooth Muscle Cell Peroxidized Fatty Acid Cholesteryl Ester Accumulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brown, M. S., and Goldstein, J. L., 1983, Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis, Annu. Rev. Biochem. 52:223–261.PubMedCrossRefGoogle Scholar
  2. Brown, M. S., Kovanen, P. T., and Goldstein, J. L., 1981, Regulation of plasma cholesterol by lipoprotein receptors, Science 212:628–635.PubMedCrossRefGoogle Scholar
  3. Fogelman, A. M., Schechter, I., Seager, J., Hokom, M., Child, J. S., and Edwards, P. A., 1980, Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages, Proc. Natl. Acad. Sci. U.S.A. 77:2214–2218.PubMedCrossRefGoogle Scholar
  4. Fowler, S., Shio, H., and Haley, N. J., 1979, Characterization of lipid-laden aorta cells from cholesterolfed rabbits, Lab. Invest. 41:372–378.PubMedGoogle Scholar
  5. Frankel, E. N., 1982, Volatile lipid oxidation products, Prog. Lipid. Res. 22:1–33.CrossRefGoogle Scholar
  6. Gerrity, R. G., 1981, The role of the monocyte in atherogenesis, Am. J. Pathol. 103:181–190.PubMedGoogle Scholar
  7. Goldstein, J. L., Ho, Y. K., Basu, S. K., and Brown, M. S., 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition, Proc. Natl. Acad. Sci. U.S.A. 76:333–337.PubMedCrossRefGoogle Scholar
  8. Henriksen, T., Mahoney, E. M., and Steinberg, D., 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by the receptor for acetylated low density lipoproteins, Proc. Natl. Acad. Sci. U.S.A. 78:6499–6503.PubMedCrossRefGoogle Scholar
  9. Henriksen, T., Mahoney, E. M., and Steinberg, D., 1982, Interactions of plasma lipoproteins with endothelial cells, Ann. N.Y. Acad. Sci. 401:102–115.PubMedCrossRefGoogle Scholar
  10. Henriksen, T., Mahoney, E. M., and Steinberg, D., 1983, Enhanced macrophage degradation of biologically modified low density lipoproteins, Arteriosclerosis 3:149–159.PubMedCrossRefGoogle Scholar
  11. Kesaniemi, Y. A., Witztum, J. L., and Steinbrecher, U. P., 1983, Receptor-mediated catabolism of low density lipoprotein in man, J. Clin. Invest. 71:950–959.PubMedCrossRefGoogle Scholar
  12. Miller, N. E., Weinstein, D. B., and Steinberg, D., 1978, Uptake and degradation of high density lipoprotein: Comparison of fibroblasts from normal subjects and from homozygous familial hy-percholesterolemic subjects, J. Lipid. Res. 19:644–653.PubMedGoogle Scholar
  13. Pittman, R. C., Carew, T. E., Attie, A. D., Witztum, J. L., Watanabe, Y., and Steinberg, D., 1982, Receptor-dependent and receptor-independent degradation of low density lipoproteins in normal rabbits and in receptor-deficient mutant rabbits, J. Biol. Chem. 257:7994–8000.PubMedGoogle Scholar
  14. Schaffner, T., Taylor, K., Bantucci, E. J., Fischer-Dzoga, K., Beenson, J. H., Glagov, S., and Wissler, R., 1980, Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages, Am. J. Pathol. 100:57–80.PubMedGoogle Scholar
  15. Semenkovitch, C. F., Ostlund, R. E., Levy, R. A., and Osa, S. R., 1982, Low density lipoprotein receptor activity in homozygous familial hypercholesterolemia fibroblasts, J. Biol. Chem. 254:7141–7146.Google Scholar
  16. Steinberg, D., 1983, Lipoproteins and atherosclerosis. A look back and a look ahead, Arteriosclerosis 3:283–301.PubMedCrossRefGoogle Scholar
  17. Steinbrecher, U. P., and Witztum, J. L., 1984, Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism, Diabetes 33:130–134.PubMedCrossRefGoogle Scholar
  18. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., and Steinberg, D., 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. U.S.A. 81:3883–3887.PubMedCrossRefGoogle Scholar
  19. Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., and Steinberg, D., 1985a, Catabolism of oxidized LDL in cultured macrophages and in vivo is mediated by the scavenger receptor pathway, Clin. Invest. Med. 8:75A.Google Scholar
  20. Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., and Steinberg, D., 1985b, Endothelial cells released reactive oxygen intermediates that cause modification of the lipid and protein components of low density lipoproteins, Clin. Res. 33:66A.Google Scholar
  21. Tappel, A. L., 1980, Measurement of and protection from in vivo lipid peroxidation, in: Free radicals in biology ,Vol. IV (W. B. Pryor, ed.), Academic Press, New York, pp. 1–47.Google Scholar
  22. Tsuchida, M., Miura, T., Mizutani, K., and Aibara, K., 1985, Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation, Biochim. Biophys. Acta 834:196–204.PubMedGoogle Scholar
  23. Weisgraber, K. H., Innerarity, T. L., and Mahley, R. W., 1978, Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts, J. Biol. Chem. 253:9053–9062.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Urs Peter Steinbrecher
    • 1
  1. 1.Division of Gastroenterology, Department of MedicineHealth Sciences Centre HospitalVancouverCanada

Personalised recommendations